Scott Gottlieb, M.D., is a practicing physician and a resident fellow at the American Enterprise Institute. From 2005 to 2007, he served as the FDA deputy commissioner for medical and scientific affairs and before that, from 2003 to 2004, as the FDA’s director of medical policy development. He left the FDA to work on the implementation of the new medicare drug benefit as a senior adviser to the administrator of Medicare and Medicaid Services. Gottlieb is an editorial board member of the journal Value Based Cancer Care and the Food and Drug Law Institute’s Policy Forum, and he writes a regular column for the Wall Street Journal. He is also a clinical assistant professor at the New York University School of Medicine.
Dr. Scott Gottlieb has also participated in: